[ASND] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
07-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 46.45%
YoY- 58.11%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 36,180 95,894 137,702 48,034 47,393 33,589 22,896 35.70%
PBT -104,354 -128,527 -81,088 -161,578 -121,862 -109,617 -202,069 -35.65%
Tax -230 2,508 5,790 645 -429 1,297 5,349 -
NP -109,933 -131,035 -86,878 -162,223 -121,433 -110,914 -207,418 -34.53%
Tax Rate - - - - - - - -
Total Cost 146,113 226,929 224,580 210,257 168,826 144,503 230,314 -26.18%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -303.85 -136.65 -63.09 -337.73 -256.23 -330.21 -905.91 -51.75%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.92 -2.30 -1.53 -2.88 -2.16 -1.98 -3.70 -35.45%
EPS Diluted -1.92 -2.30 -1.53 -2.88 -2.16 -1.98 -3.70 -35.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.